A Novel Prognostic Biomarker CCR8 for Gastric Cancer and Anti-CCR8 Blockade Attenuate the Immunosuppressive Capacity of Tregs In Vitro
Cancer Biotherapy and Radiopharmaceuticals · 2023
DOI: 10.1089/cbr.2022.0095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2023. Verfasst von Zhigang Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Southeast University, Nanjing, China. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Stomach Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical School of Southeast University, Nanjing, China.
- Department of General Surgery, Zhongda Hospital Affiliated to Southeast University, Nanjing, China.
- Department of Pathology, Zhongda Hospital Affiliated to Southeast University, Nanjing, China.
ORCID-Profile: Long Zhu
Zitieren
APA
Zhang, Z., Wang, G., Shao, X., Wu, H., Su, X., Zhu, L., & Ji, Z. (2023). A Novel Prognostic Biomarker CCR8 for Gastric Cancer and Anti-CCR8 Blockade Attenuate the Immunosuppressive Capacity of Tregs In Vitro. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2022.0095
Vancouver
Zhang Z, Wang G, Shao X, Wu H, Su X, Zhu L, et al. A Novel Prognostic Biomarker CCR8 for Gastric Cancer and Anti-CCR8 Blockade Attenuate the Immunosuppressive Capacity of Tregs In Vitro. Cancer Biotherapy and Radiopharmaceuticals. 2023. doi:10.1089/cbr.2022.0095
BibTeX
@article{Zhang2023,
author = {Zhang, Zhigang and Wang, Guoqing and Shao, Xiangyu and Wu, Hailu and Su, Xiangyu and Zhu, Long and Ji, Zhenling},
title = {A Novel Prognostic Biomarker CCR8 for Gastric Cancer and Anti-CCR8 Blockade Attenuate the Immunosuppressive Capacity of Tregs In Vitro},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
year = {2023},
doi = {10.1089/cbr.2022.0095}
}
EUVIMED